Qiao-Ling Wu

Prof. Qiao-Ling Wu


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Drug Design, Development and Therapy
Verified
Journal Article
Open access
PDF file
BDBo-Ran Deng
Bo-Ran Deng
YZYang Zhang
Yang Zhang
ZXZi-Feng Xie
Zi-Feng Xie
DWDing-Ding Wang
Ding-Ding Wang
TZTao Zeng
Tao Zeng
QWQiao-Ling Wu
Qiao-Ling Wu
Purpose: The debate continues over the differential impact of remimazolam vs propofol on hemodynamic stability. This study aims to elucidate the effects of a combination of remimazolam and esketamine vs propofol and esketamine on hemodynamic parameters in elderly patients undergoing painless colonoscopies. Patients and Methods: We conducted a randomized controlled trial involving 754 patients, divided equally between two treatment groups. The remimazolam-esketamine group (RE group) received 0.15 mg/kg of remimazolam and 0.3 mg/kg of esketamine. Conversely, the propofol-esketamine group (PE group) was administered 1.5 mg/kg of propofol with 0.3 mg/kg of esketamine. Primary outcomes focused on the incidence of hypotension. Secondary outcomes assessed were other hemodynamic adverse events, intraoperative blood pressure and heart rate fluctuations, usage of vasoactive agents, sedation efficacy, and additional adverse reactions. Results: Hypotension occurred significantly less frequently in the RE group (9.78%, 95% confidence interval[CI]: 6.67– 12.87%) compared to the PE group (23.57%, 95% CI: 21.22– 30.52%), P< 0.001. The RE group also showed lower incidences of sinus tachycardia, sinus bradycardia, and required less support from vasoactive agents (P< 0.001). Additionally, the RE group experienced smaller fluctuations in blood pressure and heart rate (P< 0.05). Both groups achieved a 100% sedation success rate. Notably, the RE group had a longer induction period but a quicker recovery time (P< 0.001), and lower rates of respiratory depression (P=0.006) and injection pain (P< 0.001). Conclusion: Remimazolam combined with esketamine offers superior hemodynamic stability and significantly reduces adverse event rates compared to propofol plus esketamine in elderly patients undergoing painless colonoscopies, while maintaining effective sedation.

3 December 2024 in Journal of Applied Toxicology
Verified
Journal Article
Closed access
SHShi‐Rui Hao
Shi‐Rui Hao
ZXZi‐Feng Xie
Zi‐Feng Xie
JLJia‐Xin Li
Jia‐Xin Li
QWQin‐Zhi Wang
Qin‐Zhi Wang
TWTing‐Ting Wu
Ting‐Ting Wu
QWQiao-Ling Wu
Qiao-Ling Wu

3 December 2025 in BMC Anesthesiology
Verified
Journal Article
Open access
PDF file
ZXZi-Feng Xie
Zi-Feng Xie
BDBo-Ran Deng
Bo-Ran Deng
YGYuan Gao
Yuan Gao
YZYi-Dan Zhang
Yi-Dan Zhang
YMYu-Ting Meng
Yu-Ting Meng
QWQiao-Ling Wu
Qiao-Ling Wu
To evaluate the safety and efficacy of dexmedetomidine combined with butorphanol for postoperative analgesia in patients undergoing posterior spinal surger